Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism HDAC1 inhibitors(Histone deacetylase 1 inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute myocardial infarction | Preclinical | United States | 31 Oct 2024 | |
| Reperfusion Injury | Preclinical | United States | 31 Oct 2024 |





